Headache & Migraine
Conference Coverage
Can a puff of cool air up the nose stop acute migraine?
Most patients reported relief of their symptoms after receiving 15 minutes of transnasal evaporative cooling, without any need for rescue...
Conference Coverage
Migraine device expands treatment possibilities
New studies of remote electrical neuromodulation show efficacy in adolescents and safety during pregnancy.
Conference Coverage
Cannabis RCT shows efficacy, AEs in migraine
First RCT in migraine suggests THC/CBD mix might be best, and that recreational doses may be higher than necessary.
Conference Coverage
Migraine clusters emerge from machine-learning analysis
Groupings somewhat reflect expert consensus, but also suggest therapeutic avenues.
Expert Perspective
Update on Migraine Prevention 2023
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
News
FDA expands atogepant approval to include chronic migraine
The approval makes atogepant the first, and only, oral CGRP receptor antagonist approved to prevent migraine across frequencies, including...
Conference Coverage
Atogepant prevents episodic migraine in some difficult-to-treat cases
Initial results showed patients receiving oral atogepant had significantly fewer mean monthly migraine days, achieved 50% or greater reduction in...
News
Headache before the revolution: A clinician looks back
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
News
Migraine after concussion linked to worse outcomes
Although most children recover quickly from a concussion, approximately one-third continue to report symptoms a month after the event.